MAJI
Marijuana Inc.0.0540
-0.0160-22.9%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
2.21MP/E (TTM)
-Basic EPS (TTM)
-0.14Dividend Yield
0%Recent Filings
10-Q
Q1 FY2021 results
GRN Holding, a shell company, posted zero revenue and a $189,376 operating loss for Q1 FY2021 ended October 31, 2020, up from $30,783 y/y on higher general and administrative costs like legal and investor relations. Six-month net loss hit $384,899 versus $25,180 prior year, fully matching operating loss with no material other items. Cash grew to $19,201 on $61,321 related-party advances, covering $42,120 operating outflow, yet liabilities topped $444k including $72k note payable and $175k related-party loans. Letters of intent signed for related-party buys like Sunshine Hemp and Pacific Merchant Processing, pending definitive deals. Ongoing litigation clouds funding. Disclosure controls ineffective.
10-Q
Q2 FY2021 results
GRN Holding, a shell company hunting deals, posted zero revenue for Q2 FY2021 ended January 31, 2021, with operating loss shrinking 45% y/y to $133,625 from $242,917 while YTD loss widened to $686,168 from $300,478, driven by lower general and administrative costs like legal and compliance fees. Cash ticked up to $128, fully funded by $61,321 in related-party advances against $444,776 liabilities including $72,090 note payable and $174,884 related-party loans; operating cash burn eased to $61,193 (derived). No acquisitions closed; letters of intent signed for related-party targets like Sunshine Hemp. Leadership swapped in April 2022 with 144M-share sale for $140,000. Ongoing litigation risks linger.
8-K
Auditor resigns cleanly
10-Q
Q1 FY2021 results
GRN Holding, a shell company, posted no revenue for Q1 FY2021 ended July 31, 2020, with operating loss widening to $62,917 (up 135% y/y from $26,778) on higher legal and compliance costs, while net loss hit $76,742 after a $13,825 insurance cancellation loss—versus $5,603 net income prior year from liability settlements. Related-party loans swelled to $236,205, fully funding $61,321 operating cash burn; cash stayed at zero. No capex, so free cash flow not disclosed in the 10-Q. Letters of intent signed for related-party acquisitions in hemp, merchant processing, and cannabis finance, pending definitive agreements. Disclosure controls ineffective. Litigation clouds liquidity.
8-K
Authorized shares tripled
GRN Holding boosted authorized shares from 260M to 760M on August 22, 2020, via board and majority stockholder approval. Board also created Series A Preferred Stock—100 shares issued to Justin Costello—with super-voting rights securing majority control on all matters. This locks in leadership sway. Amendments pending Nevada filing.
IPO
Website
Employees
Sector
Industry
ACB
Aurora Cannabis Inc.
5.53+0.41
BUDZ
WEED, Inc.
0.06+0.01
CBSTF
THE CANNABIST COMPANY HOLDINGS
0.10+0.03
CRON
Cronos Group Inc. Common Share
3.16+0.11
GCAN
Greater Cannabis Co Inc.
0.08+0.00
GRUSF
Grown Rogue International Inc.
0.44+0.03
GSTK
Growth Stalk Holdings Corp
3.00+0.00
GTBIF
Green Thumb Industries Inc.
9.63+1.23
IMCC
IM Cannabis Corp.
1.73+0.21
MRMD
MariMed Inc.
0.12+0.01